Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
A study to assess the biochemical and immunomodulatory effects of BXCL701 in pancreatic cancer.
Description: To measure how BXCL701 effects the tumor by measuring the rate of tumor cell death or the reduction of tumor cell growth. This will be measured by scans and blood work.
Measure: To characterize the quantitative and qualitative effects of BXCL701 on relevant immune effector cytokines and various immunological effector cells that are consistent with its known mechanism of action. Time: Up to 37 days post treatmentDescription: assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events
Measure: Evaluate the tolerability of exposure to BXCL701: National Cancer Institute Common Terminology Criteria Time: Up to 37 days post treatmentDescription: Measure the rate of cancer cell death measured by histological staining methods of post-treatment biopsied tissue.
Measure: Evaluate the effect of exposure to BCXL701 on cancer cell death Time: Up to 37days post treatmentDescription: Genomic analysis is the identification, measurement or comparison of genomic features such as DNA sequence, structural variation, gene expression, or regulatory and functional element annotation at a genomic scale.
Measure: Genomic analysis before and after treatment. Time: Up to 37 days post treatmentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports